These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8380055)

  • 1. ras gene mutations and HPV infection are common in human laryngeal carcinoma.
    Anwar K; Nakakuki K; Naiki H; Inuzuka M
    Int J Cancer; 1993 Jan; 53(1):22-8. PubMed ID: 8380055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of synergistic association between human papillomavirus and ras gene point mutation in laryngeal carcinomas.
    Shidara K; Suzuki T; Hara F; Nakajima T
    Laryngoscope; 1994 Aug; 104(8 Pt 1):1008-12. PubMed ID: 8052064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of ras oncogene mutations and human papillomavirus DNA in human prostate carcinomas.
    Anwar K; Nakakuki K; Shiraishi T; Naiki H; Yatani R; Inuzuka M
    Cancer Res; 1992 Nov; 52(21):5991-6. PubMed ID: 1382850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
    Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J
    Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Over-expression of p53 protein in human laryngeal carcinoma.
    Anwar K; Nakakuki K; Imai H; Naiki H; Inuzuka M
    Int J Cancer; 1993 Apr; 53(6):952-6. PubMed ID: 8386140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H-ras oncogene mutation and human papillomavirus infection in oral carcinomas.
    Anderson JA; Irish JC; McLachlin CM; Ngan BY
    Arch Otolaryngol Head Neck Surg; 1994 Jul; 120(7):755-60. PubMed ID: 7912510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis and clinical implications of K-ras gene mutations and infection with human papillomavirus types 16 and 18 in primary adenocarcinoma of the uterine cervix.
    Tenti P; Romagnoli S; Silini E; Pellegata NS; Zappatore R; Spinillo A; Zara C; Ranzani GN; Carnevali L
    Int J Cancer; 1995 Feb; 64(1):9-13. PubMed ID: 7665253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low incidence of H-, K- and N-ras oncogene mutations in cytological specimens of laryngeal tumours.
    Rizos E; Sourvinos G; Arvanitis DA; Velegrakis G; Spandidos DA
    Oral Oncol; 1999 Nov; 35(6):561-3. PubMed ID: 10705090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papilloma virus infection and Ki-ras oncogene in paraffin-embedded squamous carcinomas of the cervix.
    Falcinelli C; Luzi P; Alberti P; Cosmi EV; Anceschi MM
    Gynecol Obstet Invest; 1993; 36(3):185-8. PubMed ID: 8244195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
    Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T
    Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between c-Ki-ras mutations, HPV types, and prognostic indicators in invasive endocervical adenocarcinomas.
    Koulos JP; Wright TC; Mitchell MF; Silva E; Atkinson EN; Richart RM
    Gynecol Oncol; 1993 Mar; 48(3):364-9. PubMed ID: 8385060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of prevalence of human papillomavirus in laryngeal carcinomas. Study of 40 cases using polymerase chain reaction and consensus primers.
    Brandwein MS; Nuovo GJ; Biller H
    Ann Otol Rhinol Laryngol; 1993 Apr; 102(4 Pt 1):309-13. PubMed ID: 8386490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of ras point mutations and human papillomavirus 16 and 18 in cervical carcinomata and their metastases.
    Willis G; Jennings B; Ball RY; New NE; Gibson I
    Gynecol Oncol; 1993 Jun; 49(3):359-64. PubMed ID: 8390962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations of p53 and human papillomavirus infection in cervical carcinoma.
    Paquette RL; Lee YY; Wilczynski SP; Karmakar A; Kizaki M; Miller CW; Koeffler HP
    Cancer; 1993 Aug; 72(4):1272-80. PubMed ID: 8393371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.
    Wilentz RE; Chung CH; Sturm PD; Musler A; Sohn TA; Offerhaus GJ; Yeo CJ; Hruban RH; Slebos RJ
    Cancer; 1998 Jan; 82(1):96-103. PubMed ID: 9428484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in K-ras codon 12 mutation frequency between "high-risk" and "low-risk" HPV-infected samples.
    Golijow CD; Mourón SA; Gómez MA; Dulout FN
    Gynecol Oncol; 1999 Oct; 75(1):108-12. PubMed ID: 10502435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-myc and c-Ha-ras cellular oncogenes and human papillomaviruses in benign and malignant cutaneous lesions.
    Pelisson I; Soler C; Pechoux C; Chignol MC; Viac J; Euvrard S; Chardonnet Y
    J Dermatol Sci; 1992 Jan; 3(1):56-67. PubMed ID: 1317208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of human papillomavirus in laryngeal carcinoma with digoxigenin labelled probe prepared by polymerase chain reaction].
    Zhao S; Ye Q; Lu S
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Mar; 13(1):13-6. PubMed ID: 12759943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral DNA detection and RAS mutations in actinic keratosis and nonmelanoma skin cancers.
    Zaravinos A; Kanellou P; Spandidos DA
    Br J Dermatol; 2010 Feb; 162(2):325-31. PubMed ID: 19849697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infection of human papillomavirus (HPV) and Epstein-Barr virus (EBV) and p53 expression in human esophageal carcinoma.
    Khurshid A; Kazuya N; Hanae I; Manabu I
    J Pak Med Assoc; 1998 May; 48(5):138-42. PubMed ID: 9813975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.